HEMORRHAGIC AND NECROTIC TOXINS IN SNAKE VENOMS
蛇毒中的出血性和坏死性毒素
基本信息
- 批准号:2291672
- 负责人:
- 金额:$ 2.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1993
- 资助国家:美国
- 起止时间:1993-09-30 至 1997-08-31
- 项目状态:已结题
- 来源:
- 关键词:Baculoviridae animal genetic material tag anticoagulants complementary DNA drug design /synthesis /production fibrinolytic agents gel filtration chromatography genetic library immunoaffinity chromatography messenger RNA protein sequence recombinant proteins snakes thrombin tissue /cell culture toxin transfection /expression vector
项目摘要
Snake venom is a mixture of proteins, toxic and nontoxic components. It
has been known that venoms of some Crotalidae and Viperidae have
anticoagulation activity. Recent work in our laboratory and also in Dr.
Siigur's laboratory isolated fibrinolytic enzymes without toxic action
from the venoms of Vipera lebetina (lebetase) and Crotalus Atrox
(atroxase). Thrombosis is a leading killer throughout the world, and it
is important to find better thrombolytic agents than those currently used
such as tpA, urokinase, and streptokinase. Lebetase, atroxase, and other
fibrinolytic enzymes from snake venoms are potentially useful
thrombolytic agents after the removal of toxic components from snake
venoms.
It is proposed that base sequence of cDNA encoded for lebetase will be
determined. For this purpose mRNA will be first isolated from venom
glands of Vipera lebetina. Lebetase gene will be isolated and sequenced.
Recombinant lebetase will also be produced by packaging lebetase gene
into baculovirus transfer vector. The cloned lebetase will be compared
with the enzyme isolated from Vipera lebetina venom. Once cloned lebetase
is shown to be identical to the natural one, fibrinogenase activity can
be increased by modifying the enzyme in the future. Our proposed work may
produce a new potent thrombolytic agent.
蛇毒是蛋白质、有毒和无毒成分的混合物。它
众所周知,一些响尾蛇科和蝰蛇科的毒液具有
抗凝活性。我们实验室以及博士的最新工作。
Siigur实验室分离出无毒性作用的纤溶酶
来自 Vipera lebetina (lebetase) 和 Crotalus Atrox 的毒液
(阿托氧化酶)。血栓形成是全世界的头号杀手,
找到比目前使用的更好的溶栓剂非常重要
例如tpA、尿激酶和链激酶。 Lebetase、阿托酶等
蛇毒中的纤溶酶具有潜在用途
蛇体内有毒成分去除后的溶栓剂
毒液。
建议编码 lebetase 的 cDNA 的碱基序列为
决定。为此,首先从毒液中分离出 mRNA
Vipera lebetina 的腺体。 Lebetase 基因将被分离并测序。
重组lebetase也将通过包装lebetase基因来生产
转入杆状病毒转移载体。将比较克隆的lebetase
用从 Vipera lebetina 毒液中分离出的酶。一旦克隆了lebetase
被证明与天然纤维蛋白原酶相同,纤维蛋白原酶活性可以
将来可以通过修饰酶来增加。我们提出的工作可能
生产一种新的强效溶栓剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANTHONY T TU其他文献
ANTHONY T TU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANTHONY T TU', 18)}}的其他基金
相似海外基金
Patterns of background nucleotide substitution in the human lineage
人类谱系中背景核苷酸取代的模式
- 批准号:
7077029 - 财政年份:2006
- 资助金额:
$ 2.45万 - 项目类别:
Assessing Mobile Element-based Mutagenic Recombination
评估基于移动元件的诱变重组
- 批准号:
7155693 - 财政年份:2006
- 资助金额:
$ 2.45万 - 项目类别:
Antioxidant Enzymes and Cell Cycle Checkpoint Pathways
抗氧化酶和细胞周期检查点途径
- 批准号:
7102437 - 财政年份:2006
- 资助金额:
$ 2.45万 - 项目类别: